Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

A Study of CK-1827452 Infusion in Stable Heart Failure

NCT00624442 ·Status: COMPLETED ·Phase: PHASE2

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

NCT01035255 ·Status: TERMINATED ·Phase: PHASE3

Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure

NCT01982292 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

NCT06979362 ·Status: RECRUITING ·Phase: PHASE2

Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure

NCT04468529 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

NCT05949801 ·Status: COMPLETED ·Phase: PHASE3

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

NCT01316432 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure

NCT00303498 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

NCT03036124 ·Status: COMPLETED ·Phase: PHASE3

Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453

NCT02840565 ·Status: COMPLETED ·Phase: PHASE1

Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

NCT04218435 ·Status: COMPLETED

Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure

NCT00913653 ·Status: COMPLETED ·Phase: PHASE2

BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients

NCT06439069 ·Status: RECRUITING

A Study of CLR325 in Chronic Stable Heart Failure Patients.

NCT02696967 ·Status: COMPLETED ·Phase: PHASE2

The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients

NCT03300427 ·Status: COMPLETED ·Phase: PHASE4

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

NCT00043758 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

NCT01922089 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

NCT03756285 ·Status: TERMINATED ·Phase: PHASE2

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

NCT02768298 ·Status: COMPLETED ·Phase: PHASE4

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

NCT00132886 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

NCT02468232 ·Status: COMPLETED ·Phase: PHASE3

Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.

NCT03388593 ·Status: RECRUITING ·Phase: PHASE3

Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy

NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2

The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure

NCT04688294 ·Status: COMPLETED ·Phase: PHASE4

Interleukin-1 Blockade in Recently Decompensated Heart Failure

NCT01936909 ·Status: COMPLETED ·Phase: PHASE2/PHASE3